IMPORTANT: Updated Interim Clinical Considerations for use of COVID-19 Vaccines Currently Authorized in the United States

Michigan Dept of Health & Human Services sent this bulletin at 05/04/2023 08:06 AM EDT

MDHHS banner with logo no names

This message was sent to AIM, FAB, Health Systems, INE, IAP, LHD Health Officers, LHD Medical Directors, MACI, MACI 2, PH Imms Leads, MCIR Region Contacts, COVID-19 Vaccine Providers, and Imms All Staff. I apologize for any duplications

Dear Immunization Partners,

Please share the following information with providers in your jurisdiction.

On May 1, 2023, the Centers for Disease Control and Prevention (CDC) updated their Interim Clinical Considerations for use of COVID-19 Vaccines Currently Authorized in the United States.

Summary of recent changes include:

  • Revision of the mRNA COVID-19 vaccination schedule for people who are moderately or severely immunocompromised as follows:

    • At the time of initial vaccination, immunocompromised people ages 6 months and older are recommended to receive 3 bivalent mRNA doses

    • Immunocompromised people ages 6 months and older who previously received only monovalent doses are recommended to receive 1 or 2 bivalent mRNA vaccine doses, depending on age and vaccine product

    • Immunocompromised people who previously received a bivalent mRNA vaccine dose(s) have the option to receive 1 or more additional bivalent mRNA doses

  • Updates to Appendix D: Vaccine administration errors and deviations addresses unauthorized dose of monovalent vaccine error

Updates to Appendix D: Vaccine administration errors and deviations addresses unauthorized dose of monovalent vaccine error

Alternatives to mRNA COVID-19 vaccines remain available for people who cannot or will not receive an mRNA vaccine. CDC’s recommendations for use of (monovalent) Novavax or Janssen’s COVID-19 vaccines were not affected by the changes.

CDC, ACIP, and MDHHS will continue to monitor COVID-19 disease levels and vaccine effectiveness in the months ahead and look forward to additional discussion around potential updates this fall.

COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. CDC recommends that people get up to date with COVID-19 vaccination as soon as feasible.

Your Immunization Outreach and Education Team,

Alyssa, Andrea, Dianne, Heidi, Lisa, and Sarah